颅骨修补术的时机:对754例患者进行的10.75年单中心分析
该研究回顾性分析了单中心10.75年内754例颅骨修补术,发现术后30天死亡率为0.26%,总并发症发生率为24.6%。感染在去骨瓣减压术后<14天行修补时显著更高,脑积水与修补时机相关,新发癫痫仅见于>90天修补者。作者认为15-30天修补可能减少感染、癫痫和骨瓣吸收,而>90天可能减少脑积水但增加癫痫风险。
要点
- 去骨瓣减压术后<14天行颅骨修补感染率显著更高(p=0.007,Holm-Bonferroni校正p=0.028)。
- 脑积水与修补时机相关,每延迟10天OR为0.92(p<0.001),<90天修补者最常见。
- 新发癫痫仅见于>90天行颅骨修补的患者。
核心结论
- 去骨瓣减压术后15至30天行颅骨修补可能最大限度减少感染、癫痫和骨瓣吸收,而等待>90天可能最大限度减少脑积水但可能增加癫痫风险。
研究设计与样本
- 回顾性综述了Harborview医疗中心过去10.75年内所有颅骨修补病例,共754例,采用Cox比例风险模型分析变量。
主要发现
- 10.75年间单中心共行754例颅骨修补术,男性占60%,中位随访233天。
- 30天死亡率为0.26%(2例,均死于术后硬膜外血肿)。
- 总体24.6%的患者经历至少1种并发症,包括需取出骨瓣的感染(6.6%)、需分流术的术后脑积水(9.0%)、需合成颅骨修补的骨瓣吸收(6.3%)、癫痫(4.1%)、需清除的术后血肿(2.3%)和其他(1.6%)。
- 若颅骨修补在初次去骨瓣减压术后<14天进行,感染率显著更高(p=0.007,Holm-Bonferroni校正p=0.028)。
- 脑积水与颅骨修补时间显著相关(每增加10天OR 0.92,p<0.001),且在初次去骨瓣减压术后<90天行颅骨修补的患者中最常见。
临床怎么用
- 作者认为去骨瓣减压术后15至30天行颅骨修补可能最大限度减少感染、癫痫和骨瓣吸收,而等待>90天可能最大限度减少脑积水但可能增加癫痫风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Despite their technical simplicity, cranioplasty procedures carry high reported morbidity rates. The authors here present the largest study to date on complications after cranioplasty, focusing specifically on the relationship between complications and timing of the operation. METHODS The authors retrospectively reviewed all cranioplasty cases performed at Harborview Medical Center over the past 10.75 years. In addition to relevant clinical and demographic characteristics, patient morbidity and mortality data were abstracted from the electronic medical record. Cox proportional-hazards models were used to analyze variables potentially associated with the risk of infection, hydrocephalus, seizure, hematoma, and bone flap resorption. RESULTS Over the course of 10.75 years, 754 cranioplasties were performed at a single institution. Sixty percent of the patients who underwent these cranioplasties were male, and the median follow-up overall was 233 days. The 30-day mortality rate was 0.26% (2 cases, both due to postoperative epidural hematoma). Overall, 24.6% percent of the patients experienced at least 1 complication including infection necessitating explantation of the flap (6.6%), postoperative hydrocephalus requiring a shunt (9.0%), resorption of the flap requiring synthetic cranioplasty (6.3%), seizure (4.1%), postoperative hematoma requiring evacuation (2.3%), and other (1.6%). The rate of infection was significantly higher if the cranioplasty had been performed < 14 days after the initial craniectomy (p = 0.007, Holm-Bonferroni-adjusted p = 0.028). Hydrocephalus was significantly correlated with time to cranioplasty (OR 0.92 per 10-day increase, p < 0.001) and was most common in patients whose cranioplasty had been performed < 90 days after initial craniectomy. New-onset seizure, however, only occurred in patients who had undergone their cranioplasty > 90 days after initial craniectomy. Bone flap resorption was the least likely complication for patients whose cranioplasty had been performed between 15 and 30 days after initial craniectomy. Resorption was also correlated with patient age, with a hazard ratio of 0.67 per increase of 10 years of age (p = 0.001). CONCLUSIONS Cranioplasty performed between 15 and 30 days after initial craniectomy may minimize infection, seizure, and bone flap resorption, whereas waiting > 90 days may minimize hydrocephalus but may increase the risk of seizure.
引用
- Morton RP, Abecassis IJ, Hanson JF, et al. Timing of cranioplasty: a 10.75-year single-center analysis of 754 patients. J Neurosurg. 2017. PMID: 28799868. doi:10.3171/2016.11.JNS161917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。